Menveo 1 vial-a-c-y-w-135-DIP 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FP6ZG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $94,236
Award facts
- Contract value 100% obligated
- $94,236.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $94,236.00 to DMS Pharmaceutical Group Inc. on June 18, 2025, for the supply of Menveo 1 vial (meningococcal vaccine, groups A, C, Y, and W-135) in 0.5mL dosage form. This firm fixed-price delivery order, with an ultimate completion date of June 20, 2025, was issued without a set-aside designation. The order will be fulfilled from DMS Pharmaceutical Group's location in Park Ridge, Illinois, and represents a component of the company's broader pharmaceutical supply obligations to the federal government.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, holds a significant single-award Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026 under the SPE2DB program. This foundational IDC authorizes the issuance of delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities nationwide. The company's established role as a critical supplier in the federal pharmaceutical supply chain, combined with its proven track record delivering specialty medications and vaccines to Department of Defense healthcare sites, positions it as a reliable vendor for routine medical supply procurement such as this meningococcal vaccine delivery.
Quick answers
Who was awarded contract SPE2DB25FP6ZG?
SPE2DB25FP6ZG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FP6ZG worth?
The government has obligated $94,236 on SPE2DB25FP6ZG.
Is contract SPE2DB25FP6ZG an order under another contract?
Yes. SPE2DB25FP6ZG is a delivery order under SPE2DB22D9311, an indefinite delivery contract.
Was contract SPE2DB25FP6ZG competed?
The extent of competition for SPE2DB25FP6ZG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award